Shenzhen Weiming Xinpeng Biopharmaceutical Co., Ltd.

Peking University Weiming Bioengineering Group Co., Ltd. (abbreviated as: Weiming Group) was founded in 1992. It is one of the three major industrial groups of Peking University, mainly engaged in the biological industry, with key investments in six major fields: biopharmaceuticals, bio-agriculture, bio-energy, bio-environmental protection, bio-services, and bio-manufacturing. Over more than twenty years since its establishment, Weiming Group has adhered to the philosophy of "rejuvenating the nation through science and education, serving the nation through industry, and strengthening the nation through health," committed to "building a bio-economy system and creating a bio-economy flagship." It has formed three major advantages: "a solid industrial foundation, an innovative economic system, and a unique development approach." In the course of China's bio-industry development, it has created multiple "world firsts" and "China firsts," and has grown into a flagship enterprise of China's modern bio-industry and one of China's enterprise groups with the greatest international competitive potential. In particular, through the preliminary establishment of the world's first "bio-economy incubator," the creation of bio-economy theory, and the creation of the bio-economy model, Weiming Group has become the source of the world's bio-economy. Shenzhen Weiming Xinpeng Biopharmaceutical Co., Ltd. (abbreviated as: Weiming Xinpeng) was established in 1992. It is one of China's earliest enterprises engaged in biopharmaceutical research and industrialization, located in the advantageous Shenzhen Nanshan High-tech Park, adjacent to the scenic Songpingshan Park. As a key enterprise in the biopharmaceutical sector of Weiming Group, Weiming Xinpeng is currently a national high-tech enterprise and a Shenzhen high-tech enterprise, and has been awarded the title of "Guangdong Province Contract-abiding and Credit-worthy Enterprise" every year since 2009. The company currently has modern biopharmaceutical production plants and comprehensive facilities, advanced production equipment, and process technology. The genetically engineered products produced and sold have broad market prospects and a relatively high market share in China. The company has always focused on product research and development, actively carrying out R&D and innovation in biopharmaceuticals, while extensively seeking cooperation with leading scientific research institutions, universities, and biopharmaceutical enterprises both domestically and internationally, vigorously strengthening product R&D efforts. As a national biopharmaceutical industry base, Shenzhen regards biopharmaceuticals as a key industry for development. Bathed in this uniquely favorable industrial environment, the company will surely become a highly competitive biopharmaceutical enterprise. Weiming Xinpeng upholds the fine traditions of Weiming Group, emphasizes humanistic care, advocates an enterprising corporate spirit, and has a comprehensive welfare and security system, making it an excellent stage for displaying individual talents. To meet business development needs and strengthen professional and technical capabilities, the company plans to openly recruit talents from society in fields such as production technology, quality management, marketing, and international trade. We look forward to you becoming one of us and joining hands with Weiming Xinpeng.